A short piece of genetic code, whose only mission in life is to make more copies of itself, has bought entire countries to their knees and killed thousands of people across the world.
As the number of coronavirus cases in the world exceeds 1.4 million, the pharma industry is pushing to find new drugs, therapies and tests in the effort to bring the pandemic under control.
We speak to Bruce Hellman, CEO of uMotif, the patient-centric data capture platform specialists, to find out how virtual trials are evolving and why they are more important than ever in
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.